DefinitionBy Mayo Clinic staff
Postherpetic neuralgia (post-her-PET-ic noo-RAL-jah) is a complication of shingles, which is caused by the chickenpox (herpes zoster) virus. Most cases of shingles clear up within a few weeks. But if the pain lasts long after the shingles rash and blisters have disappeared, it's called postherpetic neuralgia.
Postherpetic neuralgia affects your nerve fibers and skin, and the burning pain associated with postherpetic neuralgia can be severe enough to interfere with sleep and appetite. The risk of postherpetic neuralgia increases with age, primarily affecting people older than 60. The area affected also makes a difference. When shingles occurs on the face, for example, the likelihood of postherpetic neuralgia is significantly higher than for other parts of the body.
Currently, there's no cure for postherpetic neuralgia, but there are treatment options to ease symptoms. For most people, postherpetic neuralgia improves over time.
Treatment of postherpetic neuralgia. American Academy of Neurology. http://www.aan.com/professionals/practice/pdfs/pn_guideline_patients.pdf. Accessed July 3, 2012.
- Bajwa ZH, et al. Postherpetic neuralgia. http://www.uptodate.com/home/index.html. Accessed July 3, 2012.
- Watson P. Postherpetic neuralgia. American Family Physician. 2011;84:690.
- Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 5th ed. Edinburgh, U.K.; New York, N.Y.: Mosby Elsevier; 2010. http://www.mdconsult.com/books/about.do?about=true&eid=4-u1.0-B978-0-7234-3541-9..X0001-6--TOP&isbn=978-0-7234-3541-9&uniqId=230100505-57. Accessed July 3, 2012.
- Ultram (tramadol hydrochloride), Ultracet (tramadol hydrochloride/acetaminophen): Label change. U.S. Food and Drug Administration. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm213264.htm. Accessed July 3, 2012.
- Watson JC (expert opinion). Mayo Clinic, Rochester, Minn. July 17, 2012.
- Irving GA, et al. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia. Clinical Journal of Pain. 2012;28:101.
- Centers for Disease Control and Prevention, et al. Update on herpes zoster vaccine: Licensure for persons aged 50 through 59 years. MMWR. 2011;60:44. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6044a5.htm?s_cid=mm6044a5_w. Accessed July 18, 2012.